世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

患者制御鎮痛ポンプの市場規模、シェア、動向分析レポート：タイプ別（電子、機械）、用途別（糖尿病、腫瘍、消化器、血液）、最終用途別、地域別、セグメント別予測、2023年～2030年


Patient-controlled Analgesic Pumps Market Size, Share & Trends Analysis Report By Type (Electronic, Mechanical), By Application (Diabetes, Oncology, Gastroenterology, Hematology), By End Use, By Region, And Segment Forecasts, 2023 - 2030

患者制御鎮痛ポンプ市場の成長と動向 Grand View Research, Inc.の最新レポートによると、患者制御鎮痛ポンプの世界市場規模は、2023年から2030年にかけて5.9%のCAGRを記録し、2030年までに6億5650万米ドルに... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ 		2023年12月1日 US$5,950
シングルユーザライセンス（印刷不可）
ライセンス・価格情報
注文方法はこちら 		110 英語

1～３営業日


　

サマリー

患者制御鎮痛ポンプ市場の成長と動向

Grand View Research, Inc.の最新レポートによると、患者制御鎮痛ポンプの世界市場規模は、2023年から2030年にかけて5.9%のCAGRを記録し、2030年までに6億5650万米ドルに達する見込みです。患者制御鎮痛薬（PCA）ポンプには、術後合併症の減少、回復の質の向上、鎮静の軽減、薬剤の最小限の使用など、いくつかの利点がある。また、PCAポンプは経口薬の服用に問題がある患者にも有用である。そのため、経口薬を服用できない患者の間で医療機器の採用が増加しており、市場の牽引役となることが予想される。さらに、COVID-19の大流行時に在宅医療の傾向が強まることも、今後数年間の市場成長を促進すると予想される。

患者制御鎮痛ポンプは、自律性の向上、術後の疼痛緩和の簡素化、安定した血行動態の維持など、小児の術後集団にとって好ましい結果をもたらす。PCRA、PCEA、非侵襲的PCAなどの革新的なPCA技術は疼痛治療の選択肢を広げ、市場成長にプラスの影響を与えると推定される。鎮痛薬に対する患者のニーズに基づいて計算される可変レート注入を含むポンプの進歩は、患者モニタリングの改善とともに、予測期間中にこのような技術の使用を強化すると予測される。

がん、関節リウマチ、線維筋痛症などの慢性疼痛疾患の症例が増加していることが、市場の成長を押し上げると予想されている。例えば、CDCによると、2019年には成人の約20.4%が慢性疼痛を抱えている。慢性痛は年齢とともに増加し、65歳以上の成人で最も高い。したがって、成人の慢性疼痛の発生が増加していることは、市場に力強い成長機会を生み出すと予測される。

患者制御鎮痛ポンプ市場レポートハイライト

- 2022年の収益シェアは北米が最大。疼痛管理に対する医療意識の高まりが地域成長を促進すると予測

- タイプ別では、電子PCAが提供するいくつかの利点により、電子セグメントが2022年に最大の収益シェアを占める

- 用途別では、持続的な癌性疼痛の管理に患者制御鎮痛ポンプが多く使用されていることから、癌分野が2022年に最大の売上シェアを占めた。

- 病院は高度な治療施設を提供し、技術的に高度な医療機器を備えているため、病院分野が最大の収益シェアを占めた。

- 在宅ケア分野は、予測期間中に最も速いCAGR 7.1％で拡大すると予測されている。



ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Patient-controlled Analgesic Pumps Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Patient-controlled Analgesic Pumps Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Patient-controlled Analgesic Pumps: Type Estimates & Trend Analysis
4.1. Patient-controlled Analgesic Pumps Market, Key Takeaways
4.2. Patient-controlled Analgesic Pumps Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Electronic
4.3.1. Electronic market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Mechanical
4.4.1. Mechanical market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Patient-controlled Analgesic Pumps: Application Estimates & Trend Analysis
5.1. Patient-controlled Analgesic Pumps Market, Key Takeaways
5.2. Patient-controlled Analgesic Pumps Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Diabetes
5.3.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Oncology
5.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Gastroenterology
5.5.1. Gastroenterology market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Hematology
5.6.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Patient-controlled Analgesic Pumps: End-use Estimates & Trend Analysis
6.1. Patient-controlled Analgesic Pumps Market, Key Takeaways
6.2. Patient-controlled Analgesic Pumps Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Specialty Clinics
6.4.1. Specialty clinics market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Home Care Settings
6.6.1. Home care settings market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Patient-controlled Analgesic Pumps Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Patient-controlled Analgesic Pumps Market by Region: Key Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Baxter.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product Benchmarking
8.2.1.4. Strategic initiatives
8.2.2. B. Braun SE
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Smiths Group plc
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Fresenius SE & Co. KGaA
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. BD
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. ICU Medical, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives

　

ページTOPに戻る


　

Summary

Patient-controlled Analgesic Pumps Market Growth & Trends

The global patient-controlled analgesic pumps market size is expected to reach USD 656.5 million by 2030, registering a CAGR of 5.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Patient-controlled Analgesic (PCA) pumps offer several advantages including fewer post-operative complications, improved quality of recovery, less sedation, and minimal use of medication. Also, PCA pumps are useful among patients that have a problem in taking oral medications. Thus, the rising adoption of the medical device among patients that are unable to take oral medications is expected to drive the market. In addition, the growing trend of home healthcare during the COVID-19 pandemic is also expected to propel market growth in the coming years.

Patient-controlled analgesic pumps have positive outcomes for the pediatric postsurgical population including increasing autonomy, simplifying pain relief in the postoperative period, and maintaining stable hemodynamics. Innovative PCA techniques such as PCRA, PCEA, and noninvasive forms of PCA have extended the options available for pain treatment and are estimated to have a positive impact on market growth. Advances in the pumps including variable-rate infusions that are calculated based on patient needs for analgesic along with improved patient monitoring are anticipated to enhance the use of such techniques during the forecast timeframe.

Rising cases of chronic pain disorders including cancer, rheumatoid arthritis, and fibromyalgia are anticipated to boost the market growth. For instance, as per the CDC, in 2019 around 20.4% of adults had chronic pain. Chronic pain increases with age and is highest among adults aged 65 and above. Hence, the rising occurrence of chronic pain among adults is anticipated to create robust growth opportunities in the market.

Patient-controlled Analgesic Pumps Market Report Highlights

• North America accounted for the largest revenue share in 2022. Increased healthcare awareness among individuals about pain management is anticipated to fuel the regional growth

• By type, the electronic segment accounted for the largest revenue share in 2022 owing to several benefits offered by electronic PCA

• By application, the oncology segment accounted for the largest revenue share in 2022 owing to high usage of patient-controlled analgesic pumps in managing sustained cancer pain

• The hospitals segment held the largest revenue share as hospital settings provide advanced treatment facilities and are equipped with technologically advanced medical devices

• The home care settings segment is projected to expand at the fastest CAGR of 7.1% over the forecast period.



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Patient-controlled Analgesic Pumps Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Patient-controlled Analgesic Pumps Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Patient-controlled Analgesic Pumps: Type Estimates & Trend Analysis
4.1. Patient-controlled Analgesic Pumps Market, Key Takeaways
4.2. Patient-controlled Analgesic Pumps Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Electronic
4.3.1. Electronic market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Mechanical
4.4.1. Mechanical market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Patient-controlled Analgesic Pumps: Application Estimates & Trend Analysis
5.1. Patient-controlled Analgesic Pumps Market, Key Takeaways
5.2. Patient-controlled Analgesic Pumps Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Diabetes
5.3.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Oncology
5.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Gastroenterology
5.5.1. Gastroenterology market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Hematology
5.6.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Patient-controlled Analgesic Pumps: End-use Estimates & Trend Analysis
6.1. Patient-controlled Analgesic Pumps Market, Key Takeaways
6.2. Patient-controlled Analgesic Pumps Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Specialty Clinics
6.4.1. Specialty clinics market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Home Care Settings
6.6.1. Home care settings market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Patient-controlled Analgesic Pumps Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Patient-controlled Analgesic Pumps Market by Region: Key Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Baxter.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product Benchmarking
8.2.1.4. Strategic initiatives
8.2.2. B. Braun SE
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Smiths Group plc
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Fresenius SE & Co. KGaA
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. BD
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. ICU Medical, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（analgesic）の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.